[Makmiror-complex in the treatment of post-radiation infectious vulvovaginitis in cancer patients].
The results of clinical trials of Makmiror-Complex for treatment of infectious vulvovaginitis of mixed etiology are discussed. The study group included 15 patients, aged 18-50, who contracted infectious vulvovaginitis of mixed etiology in the course or shortly after radiation and/or chemotherapy for tumors. The drug proved highly effective.
Borovtsova
T M
TM
Krylov
S V
SV
Udovichenko
V I
VI
D000328:Adult; D000890:Anti-Infective Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D011878:Radiotherapy / Q000009:adverse effects*; D016896:Treatment Outcome; D014848:Vulvovaginitis / Q000209:etiology* / Q000382:microbiology
D000890:Anti-Infective Agents; D000970:Antineoplastic Agents